WINNIPEG, MANITOBA -- (Marketwire) -- 05/31/11 -- Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce it has been awarded a contract by the United States Army Dental and Trauma Research Detachment (USADTRD) to develop an antibiofilm-antimicrobial wound gel formulation comprising Kane Biotech's DispersinB® antibiofilm enzyme and the US Army's KSL-W antimicrobial peptide. The awarding of this contract is part of a continued collaborative effort in accordance with the previously announced Cooperative Research and Development Agreement for Material Transfer (CRADA-MT) signed with the U.S. Army's Walter Reed Army Institute of Research.